Thymogam 250mg Injcetion

Antithymocyte Immunoglobulins is the active ingredient, which is present in thymogam 250mg injection. It is a purified and sterile form of gamma globulin. It is isolated from the hyperimmune plasma of horses immunized with human white blood cell components. It is used after kidney transplantation and other therapies to treat and delay organ rejection. After solid organ transplantation, the body generates an aggressive immune response because it recognizes the transplanted organ's antigens as a foreign antigen. Thus, treatment with immunosuppressive agents is necessary after an organ transplant to prevent organ rejection.Aplastic anemia is a condition characterized by the failure of the bone marrow to produce sufficient blood cells. Thymogam 250mg Injections are used to treat severe aplastic anemia, suppress the immune system, and reduce the immune-mediated destruction of bone marrow cells. This helps to restore normal blood cell production.

thymogam 250mg Injection is usually administered through a vein (intravenously) by your physician in a hospital setting. Your physician will decide the correct dosage and duration based on age, body weight, and disease condition.

The therapeutic effect of Thymogam 250mg Injection is the suppression of the immune response by targeting and depleting T lymphocytes. This effect is beneficial in preventing organ rejection in solid organ transplantation, where this medication helps increase the success of transplantation and improve graft survival rates. Moreover, these are used in treating conditions such as aplastic anemia and graft-versus-host disease (GVHD), where the immune system attacks the body's cells or tissues. Modulating the immune response reduces immune-mediated damage, alleviates symptoms, and promotes the restoration of normal cell production.

cold chain

1 VIAL